Spelling suggestions: "subject:"climaterelated hypersensitivity"" "subject:"cetuximabe hypersensitivity""
1 |
Cetuximab-related Hypersensitivity Reactions in Northeast TennesseeAngles, M., Bossaer, John B. 01 March 2012 (has links)
Primary Objective: To confirm the findings of several small studies conducted in the southeastern United States showing hypersensitivity infusion reaction (HIR) rates as high as 22% with the monoclonal antibody, cetuximab. Although well known for a risk of HIRs, early clinical studies showed much lower reaction rates of 3%.
|
Page generated in 0.0709 seconds